Dividends & Income
To screen ETFs by asset class, performance, yield and more, check out the
Author Following Options:
Follow this author
See their articles on your Seeking Alpha homepage and in your feed.
Real-time alerts on this author
Get their new articles emailed to you as they are published.
Daily digest on all my authors
Get all your favorite authors’ new articles emailed to you in one daily digest.
View as an RSS Feed
View SciFi Advisor's Comments
Was The Aetna News Overblown? Blue Cross Blue Shield Supports Questcor's H.P. Acthar Gel
Thanks to all the readers for the spirited comments.
Pharmaman58, I appreciate your highlight of the nature of Aetna's bulletin. Your comments definitely underscore the idea that investors may have been much to quick to react to the coverage announcements in Sept.
PeterScriabin, your comments add useful depth to what I've put fourth in the article. The article only sought to highlight the policy statement issued by BCBSKS, hence there was no attempt to rebuff other issues supporting shorts. Your post to point out the other issues is appreciated. It will be interesting to see how the remaining investor initiated class actions and off trend earnings will play out.
Jun 3, 2013. 03:32 PM
Link to Comment
Xignite quote data
© 2015 Seeking Alpha